Determination of Synthetic Impurities and Metabolic Products of F-ADAM, a Positron Emission Tomography Imaging Agent for Serotonin Transporter (SERT) Using HPLC-Tandem Mass Spectrometry
{"title":"Determination of Synthetic Impurities and Metabolic Products of F-ADAM, a Positron Emission Tomography Imaging Agent for Serotonin Transporter (SERT) Using HPLC-Tandem Mass Spectrometry","authors":"Wei‐Hsi Chen, C. Shiue","doi":"10.4236/pp.2020.1110023","DOIUrl":null,"url":null,"abstract":"A high performance liquid chromatography tandem mass \nspectrometry (HPLC-MS/MS) analytical method was developed to determine the \nidentity of impurities resulting from the synthesis of N,N-dimethyl-2-(2-amino-4-fluorophenylthio)benzyl-amine \n(F-ADAM), as well as its metabolic products by rat liver microsomes. 18F-ADAM \nis an important positive electron emission ligand commonly employed as a \nradio-imaging agent for serotonin transporter (SERT) in the brain. F-ADAM and \nits derivatives were separated using HPLC on a C4-phenyl column with an \nammonium formate aqueous buffer/acetonitrile programmed mobile phase. Synthetic \ncontaminants and metabolic products were identified using fragmentation spectra \nobtained by tandem mass spectrometry. We show that F-ADAM is unstable in \nmethanol, and propose the use of acetonitrile to generate optimal chromatogram. \nA Cl-substituted species was found to be the major impurity resulting from the \nF-ADAM synthetic process. The metabolic products \nof F-ADAM by rat liver microsomes were characterized by oxidization of the \nsulfur moiety to sulfoxide, demethylation of the dimethylamine moiety, \nand oxidative defluorination/deamination. These results elucidate the \nby-products of F-ADAM synthetic and metabolic processes, and provide direction \nfor the application of this imaging agent to biosystems properly.","PeriodicalId":20031,"journal":{"name":"Pharmacology & Pharmacy","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/pp.2020.1110023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A high performance liquid chromatography tandem mass
spectrometry (HPLC-MS/MS) analytical method was developed to determine the
identity of impurities resulting from the synthesis of N,N-dimethyl-2-(2-amino-4-fluorophenylthio)benzyl-amine
(F-ADAM), as well as its metabolic products by rat liver microsomes. 18F-ADAM
is an important positive electron emission ligand commonly employed as a
radio-imaging agent for serotonin transporter (SERT) in the brain. F-ADAM and
its derivatives were separated using HPLC on a C4-phenyl column with an
ammonium formate aqueous buffer/acetonitrile programmed mobile phase. Synthetic
contaminants and metabolic products were identified using fragmentation spectra
obtained by tandem mass spectrometry. We show that F-ADAM is unstable in
methanol, and propose the use of acetonitrile to generate optimal chromatogram.
A Cl-substituted species was found to be the major impurity resulting from the
F-ADAM synthetic process. The metabolic products
of F-ADAM by rat liver microsomes were characterized by oxidization of the
sulfur moiety to sulfoxide, demethylation of the dimethylamine moiety,
and oxidative defluorination/deamination. These results elucidate the
by-products of F-ADAM synthetic and metabolic processes, and provide direction
for the application of this imaging agent to biosystems properly.